The echocardiographic assessments showed that over-expression of miR-665 aggravated impaired LV ejection fraction (EF) and percentage of fractional shortening (FS) induced by TAC compared with control TAC mice, while restored CD34 expression in rAAV9-miR-665-treated mice eliminated the damage effects. The gene discussed is CD34; the disease is persistent truncus arteriosus.